Status:
RECRUITING
Adverse Outcome of Acute Pulmonary Embolism by Artificial Intelligence System Based on CT Pulmonary Angiography
Lead Sponsor:
Shengjing Hospital
Conditions:
Pulmonary Embolism and Thrombosis
Deterioration, Clinical
Eligibility:
All Genders
18+ years
Brief Summary
The investigators aim to build a predictive tool for Adverse Outcome of Acute Pulmonary Embolism by Artificial Intelligence System Based on CT Pulmonary Angiography.
Detailed Description
This study collected clinical, laboratory, and CT parameters of acute patients with acute pulmonary embolism from admission to predict adverse outcomes within 30 days after admission into hospital. Th...
Eligibility Criteria
Inclusion Criteria:
- age of ≥ 18 years and a pulmonary embolism diagnosis based on CT pulmonary angiography
Exclusion Criteria:
- pregnancy
- reception of reperfusion treatment before admission
- missing data regarding CT parameters, echocardiography, cardiac troponin I (c-Tn I), and N-terminal-pro brain natriuretic peptide (NT-pro BNP) levels.
Key Trial Info
Start Date :
January 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT05482269
Start Date
January 1 2011
End Date
December 31 2026
Last Update
March 11 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shengjing Hospital
Shenyang, Liaoning, China, 110004